Now, Marijuana Organization Everyday reports but a different contender prepared to jump in on this budding sector.
Atlas Biotechnologies – a Canadian licensed producer primarily based in Edmonton, Alberta – is about to take its company to Denmark and develop into a important contributor to production of healthcare marijuana.
Despite the fact that we have reported on a handful of corporations carrying out this really very same factor, Atlas’s case is a bit a lot more noteworthy than its counterparts.
Atlas acquired a exclusive home in Denmark. Rather than create its personal operation, it plans to convert a former mushroom production facility into a develop operation.
Most notably, having said that, is its size. Business COO Jeff Gossain says it is “the biggest totally indoor cannabis cultivation facility that we know of in Europe.”
Of course, this ambitious project will not come low cost. Marijuana Organization Everyday says that this facility and any extra charges connected with the commence-up will come to about $40-50 million CAD ($27-37 million USD).
In addition to possessing 170,000 square feet of development space, the facility will include 36 “individual climate-controlled rooms.”
The huge facility is anticipated to be in complete operation by late 2020.
A Superior Approach
Atlas Biotechnologies may perhaps be creating a big investment, but the firm requirements an edge when we take into account its competitors.
Marijuana Organization Everyday explains how common Denmark is to important sector players:
“Atlas follows in the footsteps of Canada-primarily based international producers Aurora Cannabis, Aphria, ICC International Cannabis, The Green Organic Dutchman and Canopy Development in picking Denmark to establish a European footprint.”
This implies that Atlas has to have a powerful benefit if it wishes to come out on best. To that finish, the firm brings two benefits.
As talked about earlier, the initial bonus is the facility’s size. Despite the fact that it will not probably be operational for a different year, it Gossain says they will possibly have a license by the finish of September for a handful of rooms, which will produce their initial harvest at the starting of 2020.
Second, Atlas will be employing climate handle, which is an great way to customize the development circumstances based on the plant in query.
As Gossain points out:
“There’s two benefits of possessing the microclimates. One particular is mitigating cross-contamination, and the second is possessing independent climates for the distinct genetics we’re going to be developing.”
Becoming in a position to preserve contamination in handle is usually beneficial, specifically provided previous incidents in Canada, such as Redecan’s problem with mould numerous months ago.
Moreover, providing the greatest feasible circumstances catered to every single strain will guarantee maximum top quality.
With these innovations, Atlas could discover it slightly much less difficult to carve its location in the European healthcare cannabis marketplace.
WeedAdvisor’s Part in Market Expansion
Seeing corporations rush overseas to expand their horizons is really encouraging, but there are also issues.
No matter how equipped a facility or firm may perhaps be, items can go incorrect – generally at terrific expense.
WeedAdvisor has noticed the consequences of items like non-compliance or sloppy management – the most current instance getting the CannTrust fiasco.
Luckily, our company options preserve each and every location covered. Compliance, security, inventory tracking, reporting and true-time information monitoring are just a handful of important functions our solutions cover. The finish outcome is an raise in general efficiency and the prevention of expensive errors or failed inspections that we all know can lead to fines in the millions of dollars.